Target intelligence / Profile preview

Mucoprotein disulfide bonds

Molecular classification
Mucin, Structural protein component
01

Overview

Mucoprotein disulfide bonds are the critical covalent cross-links that stabilize the polymeric structure of respiratory mucins, specifically MUC5AC and MUC5B (Thornton et al., 2008, Annu Rev Physiol). These bonds are formed between cysteine-rich domains of mucin monomers, creating a high-molecular-weight network that determines the viscoelastic properties of airway mucus (Fahy & Dickey, 2010, N Engl J Med). In healthy individuals, this gel-like consistency is essential for the mucociliary escalator to trap and remove inhaled particles and pathogens. However, in diseases like cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), the density of these disulfide bonds increases due to mucus hypersecretion and oxidative stress, leading to stagnant, thick mucus that obstructs the airways (Button et al., 2012, Science). Pharmacological targeting of these bonds is achieved through mucolytic agents like N-acetylcysteine (NAC), which possess a free sulfhydryl group that participates in a disulfide-sulfhydryl exchange reaction (Sadowska, 2012, Proc Am Thorac Soc). This reaction breaks the mucin polymers into smaller subunits, significantly reducing mucus viscosity and elasticity to facilitate clearance and improve respiratory function (Aldini et al., 2018, Free Radic Res).

Other names
Mucin disulfide bondsMucoprotein disulfide bridgesMucin cross-linksInter-mucin disulfide linkages
02

Mechanism of action

Reduction of inter-mucin disulfide bridges via sulfhydryl-disulfide exchange, leading to the depolymerization of mucin networks and reduction of mucus viscosity (StatPearls, 2023; Sadowska, 2012).

03

Biological functions

Mucus rheologyMucociliary clearanceAirway defenseViscoelasticity regulation
04

Disease associations

Cystic fibrosisChronic obstructive pulmonary disease (COPD)AsthmaBronchiectasisAcute bronchitis
05

Safety considerations

Induction of bronchospasm in hyperreactive patientsAirway irritationUnpleasant sulfurous odorStomatitis
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Sputum rheology (viscosity and elasticity)Mucociliary clearance (MCC) rateForced Expiratory Volume in 1 second (FEV1)

Beyond the preview

Go deeper on Mucoprotein disulfide bonds.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucoprotein disulfide bonds.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call